Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAY 60-4552 plus vardenafil in men with erectile dysfunction insufficiently responsive to vardenafil
2010-020122-18Phase 2Completed
- Sponsor
- Bayer
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in erectile dysfunction (ED) comparing BAY 60-4552 plus vardenafil, Vardenafil 20 mg and Placebo (3 arms). Primary endpoint: International Index of Erectile Function - Erectile Function subscale (IIEF-EF) severity score. Started Jun 2010; status: completed.
02
Drugs
nelociguatvardenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on 2010-020122-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020122-18.